Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
20187
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006710
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRON A (AUTHORIZED: HEPATITIS B, CHRONIC)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006710
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRON A (AUTHORIZED: AUTHORIZED: HEPATITIS C, CHRONIC)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
21487
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
21087
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRON A (AUTHORIZED: LEUKEMIA, HAIRY CELL)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
WHO-VATC |
QL03AB05
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006710
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
WHO-ATC |
L03AB05
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000175521
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
26487
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
20387
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
19187
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VIRAFERON (WITHDRAWN: HEPATITIS C, CHRONIC)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRONA (AUTHORIZED: CARCINOID TUMOR)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
20087
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
VIRAFERON (WITHDRAWN: HEPATITIS B, CHRONIC)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
20487
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRON A (AUTHORIZED: LYMPHOMA, FOLLICULAR)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
40289
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRON A (AUTHORIZED: MULTIPLE MYELOMA)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
NDF-RT |
N0000006294
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
FDA ORPHAN DRUG |
19787
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
INTRON A (AUTHORIZED: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE)
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
43K1W2T1M6
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
SUB12521MIG
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
43K1W2T1M6
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
5205
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
DB00105
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
98530-12-2
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
m6304
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | Merck Index | ||
|
C1953
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201558
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
C554127
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
8134
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
99210-65-8
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
SUPERSEDED | |||
|
100000153316
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
5880
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | RxNorm | ||
|
71306834
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
DTXSID4040509
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY | |||
|
8338
Created by
admin on Sat Dec 16 00:26:03 UTC 2023 , Edited by admin on Sat Dec 16 00:26:03 UTC 2023
|
PRIMARY |
ACTIVE MOIETY